Sponsored

Understanding the Patient Experience in Blood Cancer Treatment

December 20th 2024

Embracing Hepatic Artery Infusion Therapy for My Patients with Colorectal Cancer Liver Metastases

December 10th 2024

Exploring a Treatment Option for a Certain Subset of Patients with Non-Metastatic Castration-Sensitive Prostate Cancer (nmCSPC)

December 10th 2024

Dr. Tessa Cigler & Dr. John Ng: A patient-centered approach to a complex cancer case

December 6th 2024

Dr. Nasser Altorki: Neoadjuvant Immunotherapy and Radiation Boosts Responses in NSCLC

December 6th 2024

Addressing Disparities in Liver Cancer Care to Improve Access to First-Line Treatment for Minority and Underserved Populations with Hepatocellular Carcinoma

November 20th 2024

The Role of Biomarkers in the Treatment of Metastatic NSCLC

October 7th 2024

New Research Shows CDK5–Cyclin B1 Regulates Mitotic Fidelity

September 9th 2024

The study alters the existing paradigm that CDK1-Cyclin B1 is the only CDK-cyclin complex essential for all stages of mitosis.

New Research Offers Hope for Safer and More Effective Blood Stem Cell Transplants

September 6th 2024

Systematic identification of minor histocompatibility antigens informs outcomes after allogeneic stem cell transplantation.

A New Era of CAR-T Cell Therapy in Earlier Lines for Relapsed or Refractory Multiple Myeloma

September 4th 2024

Fox Chase Cancer Center Welcomes Dr Eric Goodlev

September 3rd 2024

Eric Goodlev, MD, has joined Fox Chase Cancer Center as an associate Professor in the Supportive Oncology and Palliative Care Program.

New Study Evaluates Practice Patterns and Management of Patients With Dermatofibrosarcoma Protuberans

September 2nd 2024

An international team of researchers led by Fox Chase Cancer Center evaluated practice patterns and the management of dermatofibrosarcoma protuberans.

Roswell Park Again Named a Top 10 New York State Employer by Forbes

August 30th 2024

Third year in a row cancer center has been ranked on this listing, based on employee surveys.

Dr. Richard Bleicher Promoted to Chief of New Division of Breast Surgery at Fox Chase Cancer Center

August 29th 2024

Richard Bleicher, MD, FACS, Clinical Director of the Breast Service Line, has been promoted to Division Chief of Breast Surgery.

Fox Chase Cancer Center Welcomes Dr. Michael Seidman

August 28th 2024

Michael Seidman, MD, has joined Fox Chase Cancer Center as a Professor in the Department of Hematology/Oncology.

Lewis Katz School of Medicine at Temple University and Fox Chase Cancer Center Researcher Receives Grant to Explore Chemotherapy’s Role in Cancer Relapse

August 26th 2024

Lucia Borriello, PhD, an Assistant Professor at the Lewis Katz School of Medicine at Temple University and Fox Chase Cancer Center, has received a $150,000 grant to explore chemotherapy’s role in cancer relapse.

The US Oncology Network Expands its Tennessee Service Area as Tennessee Cancer Specialists Joins The Network

August 20th 2024

Tennessee Cancer Specialists, the third largest oncology practice in the state, strengthens its ability to deliver cutting-edge advanced care by joining The Network.

Case Studies: Three follicular lymphoma cases treated with oral tazemetostat

August 19th 2024

Fox Chase Cancer Center Welcomes Dr. Michelle Pedersen

August 9th 2024

Fox Chase Cancer Center is pleased to announce the hiring of Michelle Pedersen, DO, as a hospitalist and Assistant Professor in the Division of Hospital Medicine within the Department of Medicine.

LSU Health New Orleans Announces Groundbreaking Research on Remdesivir’s Novel Immunological Effects

August 5th 2024

LSU Health New Orleans is proud to announce the publication of a groundbreaking study led by Giulia Monticone PhD in the prestigious journal EMBO Reports.